peptides6155.com › Faq › Regulation And Analytical Detection — Reference Sheet

Regulation And Analytical Detection — Reference Sheet

By Editorial Desk · published 2026-07-04 · last reviewed 2026-07-31 · Faq

A practical reference on WADA Prohibited List: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-07-31. Anything still debated is marked as such rather than presented as settled.

Regulation and Analytical Detection

Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.

Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.

Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.

Regulatory Status and Detection Context

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Cardarine at a glance

PropertyValueNotes
Regulatory statusProhibited in sportListed by WADA as a metabolic modulator.
Approved medical useNone in major jurisdictionsNot a registered drug.
Common test matrixUrineMost anti-doping samples use urine.
Typical detection methodLC-MS/MSDetects parent compound and metabolites.
Reference standard storage-20 °C, desiccatedTypical for analytical standards.

Mechanism and Detection Methods

Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.

Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.

GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.

Related pages on this site

Detection and Regulatory Landscape

Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.

Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.

Reference notes

=== EURATOM === The European Atomic Energy Community (EURATOM) was founded on March 25, 1957, by the Treaty of Rome between France, Italy, the Benelux countries and the Federal Republic of Germany, and remains almost unchanged to this day. Chapter 3 of the Euratom Treaty regulates measures to protect the health of the population. Article 35 requires facilities for the continuous monitoring of soil, air and water for radioactivity. As a result, monitoring networks have been set up in all Member States and the data collected is sent to the EU's central database (EURDEP, European Radiological Data Exchange Platform). The platform is part of the EU's ECURIE system for the exchange of information in the event of radiological emergencies and became operational in 1995. Switzerland also participates in this information system.

Peptidoglycan is involved in binary fission during bacterial cell reproduction. L-form bacteria and mycoplasmas, both lacking peptidoglycan cell walls, do not proliferate by binary fission, but by a budding mechanism. In the course of early evolution, the successive development of boundaries (membranes, walls) protecting first structures of life against their environment must have been essential for the formation of the first cells (cellularisation). The invention of rigid peptidoglycan (murein) cell walls in bacteria (domain Bacteria) was probably the prerequisite for their survival, extensive radiation and colonisation of virtually all habitats of the geosphere and hydrosphere.

== Regulation == Post-translational modifications of prolidase regulate its enzymatic abilities. Phosphorylation of prolidase has been shown to increase its activity while dephosphorylation leads to a decrease in enzyme activity. Analysis of known consensus sequence required for serine/threonine phosphorylation revealed that prolidase contains at least three potential sites for serine/threonine phosphorylation. Nitric oxide, both exogenously acquired and endogenously generated, was shown to increase prolidase activity in a time- and dose-dependent manner via phosphorylation at these serine and threonine sites. Additionally, prolidase may also be regulated at tyrosine phosphorylation sites, which are mediated by FAK and MAPK signaling pathways.

=== French Mandate === After the fall of the Ottoman Empire in 1918, the Syrian National Congress was convened in May 1919 in Damascus. In September 1920, Henri Gouraud, High Commissioner of the Levant, formed a representative council, with two-thirds elected and one-third appointed by the French administration. On 28 June 1922, the Syrian Federation was established, creating a Federation Council of 15 members from various states. Due to the lack of elections, these members were appointed by the High Commissioner in 1923, and their terms were extended the following year. In 1925, after the formation of the State of Syria, President Ahmad Nami and High Commissioner Henri Ponsot agreed to hold elections for a constituent assembly to draft a constitution. This led to the first Syrian legislative elections in 1928, which elected 68 representatives but was later disbanded on 5 February 1929. Article 30 of the 1930 Syrian constitution established a legislative authority known as the Chamber of Deputies, with representatives elected for four-year terms. The first elections for the Chamber of Deputies were held in December 1931 and January 1932. The first council met in June 1932 and facilitated a compromise that led to Muhammad Ali Bey al-Abid's presidency. In the 1936 elections, the National Bloc won the majority of seats in the Chamber, and Hashim al-Atassi was elected president. Concurrently, negotiations with France led to the independence treaty, ratified by the Chamber of Deputies in December 1936.

== Applications == CE–MS ability to separate analytes present in extremely low concentration with high efficiency at high speed has made it applicable in all fields of science. CE–MS has been used for bioanalytical, pharmaceuticals, environmental and forensic application. The major application of CE–MS has been for biological studies, mostly for protein and peptide analysis. For example, CE–MS is a component of analysis for both top-down and bottom-up proteomics. Along with that, it is used often for routine analysis of pharmaceutical drugs. There are number of studies reporting characterization of mixtures of peptides and proteins. CE–MS can be used for routine clinical checkup. Body fluids like blood and urine have been analyzed with CE–MS to identify biomarkers for renal diseases and cancer. CE–MS is also possible to apply for metabolomics, particularly for single-cell metabolomics due to the minute sample volume required. Neurons, frog embryos and HeLa RBC007 cells have been already analyzed using CE–MS. Analysis of cells usually includes extraction of molecules with small amount (several μl) of organic solvent prior to the CE–MS. Due to a new technique surface sampling CE–MS (SS–CE–MS) one can analyze whole tissue sections without sample preparations directly from the surface.

Sources: en.wikipedia.org

Reference notes

== Awards == In 2017, ColdHubs was shortlisted for the UK Royal Academy of Engineering's Africa Prize for Engineering Innovation. It won the 2020 Waislitz Global Citizen Disruptor Award and was the inaugural AYuTe Africa Challenge winner in 2021.

Viserys was born in 77 AC as the eldest son of Prince Baelon Targaryen and his sister-wife Princess Alyssa Targaryen. Nine days after he was born, Alyssa took Viserys riding on her dragon Meleys. Viserys' younger brother Daemon was born in 81 AC, followed by a difficult labor for Alyssa when she delivered her third son Aegon, which resulted in both of their deaths within the year. Viserys claimed the legendary but elderly dragon Balerion at age sixteen in 93 AC, flying the dragon around King's Landing with great difficulty. Balerion would die a year later in 94 AC, and Viserys would never claim another dragon again. In the same year he claimed Balerion, Viserys married his cousin Aemma Arryn, though the marriage was not consummated for another two years when Aemma turned thirteen. The two had difficulty producing a child in their early marriage, as Aemma suffered several miscarriages and gave birth to a son who passed away in infancy. Ultimately, Aemma gave birth to their daughter Princess Rhaenyra in 97 AC. Baelon passed away in 101 AC, which led King Jaehaerys Targaryen to call the Great Council of 101 AC to determine the heir to the throne. As Baelon's son, Viserys' claim to the throne prevailed over the claims of Laenor Velaryon, Princess Rhaenys Targaryen, and Laena Velaryon by a rumored vote of 20-1. Following Jaehaerys' passing in 103 AC, Viserys ascended the throne and became the fifth king to rule over the Seven Kingdoms.

Following the outbreak of the COVID-19 pandemic, the NIH-funded EcoHealth Alliance has been the subject of controversy and increased scrutiny due to its ties to the Wuhan Institute of Virology (WIV)—which has been at the center of speculation since early 2020 that SARS-CoV-2 may have escaped in a lab incident. Between 2014 and 2019, NIH awarded approximately $3.7 million in grant funding to EcoHealth Alliance, a nonprofit organization focused on global health and infectious disease research. A portion of this funding, around $600,000, was subcontracted to WIV in China as part of a project titled "Understanding the Risk of Bat Coronavirus Emergence." The project aimed to study bat coronaviruses and assess their potential to infect humans. The research at WIV included the creation of chimeric viruses, which combined genetic material from different bat coronaviruses to evaluate their ability to infect human cells. In documents released in 2021, including NIH correspondence with Congress, it was disclosed that one of these modified viruses resulted in an "unexpected outcome," where the virus became more infectious in humanized mice. The NIH maintained that this outcome was not the intended goal of the research and did not violate the terms of the grant, though critics raised concerns about potential gain-of-function research. Under political pressure, the NIH withdrew funding to EcoHealth Alliance in July 2020. In 2023, HHS barred WIV from receiving U.S. government funding for a decade, citing non-compliance with safety and reporting standards.

=== Books === Wadden, Thomas A.; Van Itallie, Theodore B. (1992). Treatment of the Seriously Obese Patient. Guilford Press. Stunkard, Albert J.; Wadden, Thomas A. (1993). Obesity: Theory and Therapy (2nd ed.). Raven Press. Brownell, Kelly D.; Wadden, Thomas A. (1998). The LEARN Program for Weight Control: Special Medication Edition. American Health Publishing. Wadden, Thomas A.; Stunkard, Albert J. (2002). Handbook of Obesity Treatment. Guilford Press. Wadden, Thomas A.; Bray, George A. (2018). Handbook of Obesity Treatment (2nd ed.). Guilford Press.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine legal to buy?

Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.

How is cardarine detected in athletes?

Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.

Does cardarine have approved medical uses?

No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.

Is cardarine approved for any medical use?

No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.

Network